ALEC (ALEC) Stock Price & Analysis
ALEC (ALEC) rose 0.00% to USD 1.48 as of July 25, 2026 at 02:22 UTC, according to Nexqual real-time market data.
ALEC last closed at USD 1.48; the session ranged USD 1.46–1.51 on volume of 311,079 shares. Market capitalization is —, with a 52-week range of USD 1.09–3.4 (NMS). Source: Nexqual, July 25, 2026 at 02:22 UTC.
Key Statistics (as of July 25, 2026 at 02:22 UTC)
| Price | USD 1.48 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.48 |
| Open | USD 1.48 |
| Day Range | USD 1.46 – 1.51 |
| 52-Week Range | USD 1.09 – 3.4 |
| Volume | 311,079 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ALEC)
Nexqual's technical model rates ALEC "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:22 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.64 (neutral) |
| vs SMA50 | Below (USD 1.81) |
| MACD | -0.11 (negative) |
From ALEC's Latest SEC 10-K Filing (filed 2026-02-25)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | USD 0.14 | ▼ 6.21% |
| STOK | Stoke Therapeutics, Inc. | USD 29.3 | ▲ 1.17% |
| DNLI | Denali Therapeutics Inc. | USD 23.11 | ▼ 2.24% |
| DTIL | Precision BioSciences, Inc. | USD 7.29 | ▼ 0.41% |
| BDTX | Black Diamond Therapeutics, Inc | USD 1.76 | ▼ 3.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:22 UTC. This page is informational and not investment advice.